MapLight Therapeutics, Inc.

MPLTNASDAQHealthcareBiotechnology

$7.66- (-)

As of Oct 26, 2026 close

Market cap: $348.00M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $7.46$40.43
Volume (live): -
Avg. volume (3M): 446.50K

MapLight Therapeutics, Inc. (MPLT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for MapLight Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy

Based on 7 unique analysts

(9 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$26.50

+245.95% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest MPLT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 5, 2026	Unknown Analyst	Guggenheim	Initiates	Hold	-
Aug 31, 2026	Ami Fadia	Needham	Reiterates	Buy	$45.00 → $43.00 −2.00 (−4.4%)
Aug 17, 2026	Sean Laaman	Morgan Stanley	Reiterates	Hold	$21.00
Aug 14, 2026	Francois Brisebois	LifeSci Capital	Maintains	Buy	$37.00
Aug 14, 2026	Evan Seigerman	BMO Capital	Maintains	Buy	$46.00 → $20.00 −26.00 (−56.5%)
Aug 13, 2026	Evan Seigerman	BMO Capital	Maintains	Buy	$46.00 → $20.00 −26.00 (−56.5%)
Aug 11, 2026	Ashwani Verma	UBS	Upgrades	Hold	$52.00 → $13.00 −39.00 (−75.0%)
Aug 10, 2026	Ashwani Verma	UBS	Downgrades	Hold	$52.00 → $13.00 −39.00 (−75.0%)
Jul 30, 2026	Unknown Analyst	Jefferies	Maintains	Buy	$25.00

Unknown Analyst

Guggenheim

HoldInitiates

Oct 5

Ami Fadia

Needham

BuyReiterates

$45.00 → $43.00

Aug 31

Sean Laaman

Morgan Stanley

HoldReiterates

$21.00

Aug 17

Francois Brisebois

LifeSci Capital

BuyMaintains

$37.00

Aug 14

Evan Seigerman

BMO Capital

BuyMaintains

$46.00 → $20.00

Aug 14

Evan Seigerman

BMO Capital

BuyMaintains

$46.00 → $20.00

Aug 13

Ashwani Verma

UBS

HoldUpgrades

$52.00 → $13.00

Aug 11

Ashwani Verma

UBS

HoldDowngrades

$52.00 → $13.00

Aug 10

Unknown Analyst

Jefferies

BuyMaintains

$25.00

Jul 30

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 5, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for MPLT?

The analyst consensus rating for MPLT is Buy, based on the latest ratings from 7 analysts over the last 90 days.

What is the average price target for MPLT?

The average 12-month price target for MPLT is $26.50, representing an upside of 246.0% from the Oct 26, 2026 close of $7.66.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.